Wednesday, November 4, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Mitochondria-made peptides emerge as preclinical analgesic candidates

Preclinical studies show the mitochondrial peptides humanin and MOTS-c reduce pain across multiple animal models by restoring mitochondrial function, suppressing oxidative stress…

PR
By Priya Raman · Science Reporter
Nov 4 05:48 ETSource: Bioengineer.org

From the source

Mitochondria-made peptides emerge as preclinical analgesic candidates

Preclinical studies show the mitochondrial peptides humanin and MOTS-c reduce pain across multiple animal models by restoring mitochondrial function, suppressing oxidative stress and inhibiting neuroinflammation.

Read at bioengineer.org
PeptiPrescribed peptides from $99/moSee all →